# US 2003/0073147 A1 · Method and device for trichomonas detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0073147 A1
- Document ID: US20030073147A1
- Status: Published application
- Kind: A1
- Application number: 10/112,410
- Filed: 2002-03-30
- Published: 2003-04-17
- Earliest claimed: 2001-07-03
- Assignees: Xenotope Diagnostics, Inc.
- Inventors: John P. Alderete; Paul C. Castella
- Web page: https://patentgrep.com/patent/US20030073147A1

## CPC

- G01N 33/54388: {based on lateral flow}
- G01N 33/56905: {Protozoa}
- G01N 2333/44: from protozoa
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method and kit for detecting Trichomonas vaginalis infection in a human subject are disclosed. In the method, a body-fluid sample such as a vaginal-swap sample or urine is obtained from the subject and contacted with an antibody specific against a Trichomonas adhesin peptide, forming an antibody-adhesin peptide complex if the subject is infected with Trichomonas. The presence or absence of the complex establishes, with a reliability of at least 80%, in the case of a vaginal swab sample, and with a reliability of at least 40% in the case of a urine sample, the presence or absence presence or absence, respectively, of Trichomonas infection in the subject. A preferred test kit employs a dry-strip, sandwich assay, format.

## Claims

### Claim 1

A method for detecting Trichomonas vaginalis infection in a human subject, with a reliability of over 80% in a vaginal swab sample from a female subject and over 40% in a urine sample from the male or female subject, comprising,
obtaining a vaginal swab or urine sample from the subject,
contacting the sample with an antibody specific against a Trichomonas adhesin peptide,
by said contacting, forming an antibody-adhesin peptide complex if the subject is infected with Trichomonas, and
detecting the presence or absence of said complex, thereby to detect the presence or absence, respectively, of Trichomonas infection in the subject, with the specified reliability.

### Claim 2 (depends on 1)

The method of claim 1, wherein the contacting antibody is immunospecific against an adhesin peptide selected from the group consisting of AP65, AP51, AP33, AP23 adhesin proteins, and immunologically reactive fragments thereof.

### Claim 3 (depends on 2)

The method of claim 2, wherein said adhesin peptide is AP65 adhesin protein.

### Claim 4 (depends on 2)

The method of claim 2, wherein said antibody is an anti-AP65 antibody.

### Claim 5 (depends on 1)

The method of claim 1, wherein said contacting, forming, and detecting steps are effective to detect Trichomonas infection from vaginal samples with a reliability of over 90%. in 68. The method of claim 1, wherein said contacting includes placing the sample on a sample-application zone of a dry strip having, in an upstream to downstream direction, the sample-application region, a reaction zone containing non-immobilized labeled antibody specific against a Trichomonas adhesin peptide, and a detection zone containing immobilized antibody specific against Trichomonas adhesin peptide in said complex, wherein (i) sample migrates in a downstream direction on said strip toward the reaction zone, (ii) adhesin peptide analyte in the sample reacts with non-immobilized antibody in the reaction zone to form a mobile labeled adhesin peptide-antibody complex, and (iii) the complex migrates toward the detection zone, (iv) said complex reacts with the immobilized antibody in the detection zone to form an immobilized labeled complex in the detection zone, and (v) non-complexed nonmobilized labeled antibody migrates downstream of the detection zone, and detecting includes detecting the presence or absence of immobilized labeled complex in the detection zone.

### Claim 6 (depends on 1)

The method of claim 1, wherein the sample obtained is a pap smear, said contacting includes forming a pap smear in the presence of labeled antibody, and the method further includes treating the pap smear to remove unbound labeled antibodies.

### Claim 7 (depends on 6)

The method of claim 6, wherein the sample obtained and contacted is the residual fluid derived from forming the pap smear.

### Claim 8 (depends on 7)

The method of claim 7, wherein the pap smearsample obtained is a liquid based pap smear exemplified by the Cytyc thin-prep pap smear.

### Claim 9 (depends on 7)

The method of claim 7, wherein the sample obtained and contacted is the residual fluid derived from forming the liquid based pap smear.

### Claim 10 (depends on 1)

The method of claim 1, for detecting Trichomonas infection in a male human subject, wherein said body fluid sample obtained is urine, and said contacting, forming, and detecting steps are effective to detect Trichomonas infection in over 40% of male human subjects infected with Trichomonas.

### Claim 11

A kit for detecting Trichomonas vaginalis infection in a human subject, with a reliability of over 80% in a vaginal swab sample from a female subject and over 40% in a urine sample from the male or female subject, comprising,
a dry-strip capable of wicking a fluid applied thereto by capillarity within the strip, said strip having, in un upstream to downstream direction, a sample-application zone, a reaction zone, and a detection zone
said reaction zone containing a non-immobilized labeled antibody specific against a Trichomonas adhesin peptide, effective to form therewith, a mobile adhesin-protein-antibody complex,
said detection zone containing immobilized antibody specific against Trichomonas adhesin peptide in said complex,
wherein, after application of a body-fluid sample to the sample-application zone, (i) sample migrates in a downstream direction on the strip toward the reaction zone, (ii) adhesin peptide analyte in the sample reacts with non-immobilized antibody in the reaction zone to form a mobile labeled adhesin peptide-antibody complex, (iii) the complex migrates toward the detection zone, (iv) the complex reacts with the immobilized antibody in the detection zone to form an immobilized labeled complex in the detection zone, and (v) non-complexed nonmobilized labeled antibody migrates downstream of the detection zone, allowing the presence or absence of Trichomonas infection in the subject to be determined by the presence or absence of detectable label in the detection zone.

### Claim 12 (depends on 11)

The kit of claim 11, wherein the non-immobilized antibody is immunospecific against an adhesin peptide selected from the group consisting of AP65, AP51, AP33, AP23 adhesin proteins, and immunologically reactive fragments thereof.

### Claim 13 (depends on 12)

The kit of claim 12, wherein said adhesin peptide is AP65 adhesin protein.

### Claim 14 (depends on 13)

The kit of claim 13, wherein the non-immobilized antibody is an anti-AP65 antibody.

### Claim 15 (depends on 14)

The kit of claim 14, wherein said antibody is produced by the cell line DM116 or cell line C55

### Claim 16

A method for detecting Trichomonas infection in a human subject, comprising,
obtaining a body-fluid sample from the subject,
contacting the sample with a Trichomonas adhesin peptide,
by said contacting, forming an antibody-adhesin peptide complex if the subject is infected with Trichomonas, and
detecting the presence or absence of said complex, thereby to establish the presence or absence, respectively, of Trichomonas infection in the subject.

### Claim 17 (depends on 16)

The method of claim 16, wherein the adhesin peptide selected from the group consisting of AP65, AP51, AP33, AP23 adhesin proteins, and immunologically reactive fragments thereof.

### Claim 18 (depends on 17)

The method of claim 17, wherein said adhesin peptide is AP65 adhesin protein.

### Claim 19 (depends on 16)

The method of claim 16, wherein said contacting includes placing the sample on a sample-application zone of a dry strip having, in an upstream to downstream direction, the sample-application region, a reaction zone containing non-immobilized Trichomonas adhesin peptide, and effective to react with anti-Trichomonas antibody present in a Trichomonas-infected individual to form a mobile antibody-adhesin peptide complex, and a detection zone containing immobilized antibody specific against human antibody, wherein (i) sample migrates in a downstream direction on said strip toward the reaction zone, (ii) anti-Trichomonas antibody analyte in the sample reacts with labeled, non-immobilized adhesin peptide in the reaction zone to form a mobile labeled adhesin peptide-antibody complex, and (iii) the complex migrates toward the detection zone, (iv) said complex reacts with the immobilized antibody in the detection zone to form an immobilized labeled complex in the detection zone, and (v) non-complexed nonmobilized labeled adhesin migrates downstream of the detection zone, and detecting includes detecting the presence or absence of immobilized labeled complex in the detection zone.
